- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: intermediate and high risk cancer of the prostate
Total 495100 results
-
Centre Georges Francois LeclercRecruitingTo Evaluate the Rate of Digestive and Urinary ToxicityFrance
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)RecruitingStage II Prostate Adenocarcinoma | Stage III Prostate AdenocarcinomaUnited States
-
University Hospital, GrenobleRecruitingRadiation Therapy, Breast Cancer, Sequential Partial Breast Irradiation | Intermediate and High-risk Luminal and Triple Negative Breast CancerFrance
-
UMC UtrechtNational University Hospital, Singapore; Berry Consultants; University of Pittsburgh... and other collaboratorsRecruitingCommunity-acquired Pneumonia, Influenza, COVID-19United Kingdom, United States, Canada, Australia, Netherlands, Croatia, Germany, Belgium, New Zealand, Ireland, Spain, Japan, Hungary, Colombia, India, Nepal, Pakistan, Portugal, Romania, Saudi Arabia
-
Sir Mortimer B. Davis - Jewish General HospitalNot yet recruiting
-
University of SydneyDana-Farber Cancer Institute; University of Southern California; Cambridge University... and other collaboratorsRecruitingGerm Cell TumorAustralia, New Zealand, United States
-
Sir Mortimer B. Davis - Jewish General HospitalRecruitingProstate CancerCanada
-
Razor GenomicsEncore ClinicalRecruitingNon-Small Cell Lung CancerUnited States, France, Germany
-
Proton Collaborative GroupRecruitingProstate CancerUnited States
-
Janssen Pharmaceutical K.K.Active, not recruiting
-
Aragon Pharmaceuticals, Inc.Active, not recruitingProstatic NeoplasmsUnited States, France, Poland, Taiwan, Ukraine, United Kingdom, China, Belgium, Germany, Spain, Israel, Mexico, Malaysia, Romania, Turkey, Canada, Netherlands, Korea, Republic of, Brazil, Russian Federation, Argentina, Sweden, Czechia
-
Janssen Research & Development, LLCActive, not recruitingProstatic NeoplasmsUnited States, Italy, Czechia, Israel, Japan, Taiwan, Korea, Republic of, United Kingdom, France, Spain, Germany, Australia, Canada, Brazil, Russian Federation, Argentina, Netherlands, Poland
-
UNICANCERIpsenActive, not recruiting
-
H. Lee Moffitt Cancer Center and Research InstituteActive, not recruitingProstate CancerUnited States
-
Albert Einstein College of MedicineActive, not recruiting
-
Memorial Sloan Kettering Cancer CenterDana-Farber Cancer InstituteActive, not recruitingProstate CancerUnited States
-
Abramson Cancer Center at Penn MedicineActive, not recruitingProstate AdenocarcinomaUnited States
-
National Cancer Institute (NCI)Canadian Cancer Trials GroupActive, not recruitingAnal Canal Cloacogenic Carcinoma | Stage III Anal Cancer AJCC v8 | Anal Margin Squamous Cell Carcinoma | Stage IIB Anal Cancer AJCC v8 | Anal Basaloid Squamous Cell CarcinomaUnited States, Canada
-
UroGen Pharma Ltd.TerminatedBladder Cancer | Urothelial Carcinoma Bladder | Urothelial CarcinomaUnited States, Israel, Russian Federation, Georgia, Bulgaria, Estonia, Latvia, Poland, Serbia, Ukraine
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingEndometrial Endometrioid Adenocarcinoma | Stage I Uterine Corpus Cancer AJCC v8 | Stage II Uterine Corpus Cancer AJCC v8United States, Puerto Rico
-
The Netherlands Cancer InstituteTerminatedProstatic NeoplasmsNetherlands
-
Eli Lilly and CompanyActive, not recruitingUrogenital Neoplasms | Prostatic Neoplasms | Neoplasm Metastasis | Enzyme Inhibitors | Antineoplastic Agents | Hormones | Physiological Effects of Drugs | Antineoplastic Agents, Hormonal | Androgens | Hormones, Hormone Substitutes, and Hormone Antagonists | Abiraterone Acetate | Steroid Synthesis Inhibitors | Cytochrome... and other conditionsChina, Canada, France, United States, Australia, Czechia, Hungary, Spain, Germany, Japan, Taiwan, Netherlands, Turkey, Mexico, Belgium, Korea, Republic of, Argentina, Romania, United Kingdom, Italy, Israel, Brazil, Poland, Greece
-
University of ChicagoActive, not recruitingProstate CancerUnited States
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedStage III Prostate Adenocarcinoma AJCC v7 | Stage II Prostate Adenocarcinoma AJCC v7 | Stage I Prostate Adenocarcinoma American Joint Committee on Cancer (AJCC) v7United States
-
Memorial Sloan Kettering Cancer CenterUniversity of Michigan; Weill Medical College of Cornell University; Janssen...Active, not recruiting
-
University of ChicagoJanssen, LPSuspendedProstate CancerUnited States
-
University of FloridaActive, not recruitingAdenocarcinoma of the ProstateUnited States
-
University of Wisconsin, MadisonUnited States Department of Defense; Prostate Cancer FoundationCompletedProstate CancerUnited States
-
Novartis PharmaceuticalsActive, not recruitingMyelodysplastic SyndromesCzechia, Hungary, Japan, Taiwan, United States, Belgium, Italy, United Kingdom, Korea, Republic of, Hong Kong, Austria, Germany, Turkey, Spain, Greece, France, Canada
-
St. Jude Children's Research HospitalNational Cancer Institute (NCI); University of Florida; The Pew Charitable TrustsActive, not recruitingBrain and Central Nervous System TumorsUnited States, Australia
-
UNICANCERSanofiActive, not recruitingAdenocarcinoma of Prostate | Progression of Prostate CancerFrance
-
European Organisation for Research and Treatment...Active, not recruitingProstate CancerGermany, Spain, France, Belgium, United Kingdom, Switzerland, Italy, Denmark
-
NYU Langone HealthPerlmutter Cancer CenterCompletedMyelodysplastic SyndromesUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedB-cell Childhood Acute Lymphoblastic Leukemia | L1 Childhood Acute Lymphoblastic Leukemia | L2 Childhood Acute Lymphoblastic Leukemia | Intermediate Risk Recurrent Childhood Acute Lymphoblastic LeukemiaUnited States, Canada, Australia, Switzerland
-
Memorial Sloan Kettering Cancer CenterCompletedProstate CancerUnited States
-
Hospices Civils de LyonActive, not recruiting
-
CelgeneCompletedMyelodysplastic SyndromesUnited States, United Kingdom, Australia, Poland, Spain, Belgium, Italy, Germany, France, Canada
-
CSSS de GatineauActive, not recruitingProstate CancerCanada
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Non-Hodgkin LymphomaUnited States
-
Ashok MuthukrishnanProgenics Pharmaceuticals, Inc.TerminatedProstate CancerUnited States
-
National Cancer Institute (NCI)Active, not recruitingClinical Stage III Cutaneous Melanoma AJCC v8 | Mucosal Melanoma | Acral Lentiginous Melanoma | Clinical Stage IV Cutaneous Melanoma AJCC v8United States
-
University of SydneyNational Health and Medical Research Council, Australia; European Organisation... and other collaboratorsActive, not recruitingProstatic NeoplasmsUnited States, Australia, United Kingdom, Spain, New Zealand, Ireland, Austria, Belgium, Slovenia
-
NRG OncologyNational Cancer Institute (NCI)SuspendedProstate Adenocarcinoma | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8Canada, United States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingRecurrent Colon Carcinoma | Recurrent Rectal Carcinoma | Rectal Adenocarcinoma | Colon Adenocarcinoma | ERBB2 Gene Amplification | Stage III Colon Cancer AJCC v7 | Stage III Rectal Cancer AJCC v7 | Stage IIIA Colon Cancer AJCC v7 | Stage IIIA Rectal Cancer AJCC v7 | Stage IIIB Colon Cancer AJCC v7 | Stage... and other conditionsUnited States, Puerto Rico
-
University Health Network, TorontoCompleted
-
Jonsson Comprehensive Cancer CenterActive, not recruitingStage III Prostate Cancer | Adenocarcinoma of the ProstateUnited States
-
Royal Marsden NHS Foundation TrustThe Institute of Cancer Research, Sutton, Surrey, UKActive, not recruitingProstate CancerNew Zealand, Ireland, United Kingdom, Canada
-
Andrei IagaruCompletedStage II Prostate Adenocarcinoma | Stage III Prostate Adenocarcinoma | Stage IV Prostate AdenocarcinomaUnited States
-
Janssen Research & Development, LLCCompleted
-
Fudan UniversityActive, not recruitingNeoadjuvant Therapy | High-risk Prostate CancerChina